Rallybio Corp (RLYB) Earnings
Rallybio Corp's most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Nov 6, 2025
From the latest earnings 8-K
Revenue • FY2025
$858K
▲ 43.0%YoY
Diluted EPS • FY2025
-$1.59
▼ 19.5%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from RLYB's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $858K | -$8.98M | — | -$1.59 | — | -3853.6% | +43.0% |
| FY2024 | $600K | -$57.77M | — | -$1.33 | -$49.28M | -10082.7% | — |
| FY2023 | $0 | -$74.56M | — | -$1.84 | -$60.28M | — | — |
| FY2022 | $0 | -$66.65M | — | -$2.09 | -$57.34M | — | — |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Nov 6, 2025 | 8-K (2.02) | 0001739410-25-000131EDGAR |
| Aug 7, 2025 | 8-K (2.02) | 0001739410-25-000108EDGAR |
| May 8, 2025 | 8-K (2.02) | 0001739410-25-000059EDGAR |
| Mar 13, 2025 | 8-K (2.02) | 0001739410-25-000029EDGAR |
| Nov 7, 2024 | 8-K (2.02) | 0001739410-24-000132EDGAR |
| Aug 8, 2024 | 8-K (2.02) | 0001739410-24-000114EDGAR |
| May 9, 2024 | 8-K (2.02) | 0001739410-24-000053EDGAR |
| Mar 12, 2024 | 8-K (2.02) | 0001739410-24-000030EDGAR |
Never miss a RLYB filing.
Get an email when RLYB files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 9, 2026Source: SEC EDGAR.